TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01256814

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SystemCHANGE-HIV
Description: SystemCHANGE, is based on social ecological theory and focuses on redesigning the family environment and daily routines that are linked to health behavior. This framework emphasizes context and specifies that change is best accomplished by: identifying a measurable goal, examining the system processes surrounding attainment of that goal, listing several ideas that may improve the system, engaging in a series of experiments to test the best ideas to improve the process, implementing the most successful ideas based on data from the experiments, and monitoring the system to maintain the gains. The SystemCHANGE-HIV intervention works to help participants make small environmental changes made in family daily routines that will eventually construct an environment.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SystemCHANGE-HIV
Description: SystemCHANGE, is based on social ecological theory and focuses on redesigning the family environment and daily routines that are linked to health behavior. This framework emphasizes context and specifies that change is best accomplished by: identifying a measurable goal, examining the system processes surrounding attainment of that goal, listing several ideas that may improve the system, engaging in a series of experiments to test the best ideas to improve the process, implementing the most successful ideas based on data from the experiments, and monitoring the system to maintain the gains. The SystemCHANGE-HIV intervention works to help participants make small environmental changes made in family daily routines that will eventually construct an environment.
Study: NCT01979822

Intervention type: OTHER
Intervention: PH patients with LenusPro pump
Description: Observation/measurement of complications in PH patients with LenusPro pump in the frist six month after implantation of pump
Study: NCT04380688

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acalabrutinib
Description: Acalabrutinib administered orally
Study: NCT01894750

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: group-based skill building self-care program
Study: NCT00725127

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aspirin
Description: 100 mg/day upon awakening for five years

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aspirin
Description: 100 mg/day at bedtime for five years
Study: NCT01112163

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Enhanced external counter pulsation
Description: While an individual is undergoing ECP, they have pneumatic stockings (also known as cuffs) on their legs and are connected to telemetry monitors that monitor their heart rate and rhythm.The cuffs should ideally inflate at the beginning of diastole and deflate at the beginning of systole. During the inflation portion of the cycle, the calf cuffs inflate first, then the lower thigh cuffs and finally the upper thigh cuffs. Inflation is controlled by a pressure monitor, and the cuffs are inflated to about 300 mmHg.
Study: NCT03542721

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-5515
Description: Crataegi ethanol extract, Garlic oil, Ginkgo leaf extract, Melissa folium extract (three times a day)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of DA-5515
Description: Placebo (three times a day)
Study: NCT03621683

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: blood rich plasma platelets
Description: Injection of blood rich platelet into the ovaries.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: blood rich plasma platelets
Description: Injection of blood rich platelet into the ovaries.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Antioxidant therapy
Description: Antioxidants:~Q10, DHEA, Vitamina E, Vitamin C, Omega 3

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy
Description: Antioxidants:~Q10, DHEA, Vitamina E, Vitamin C, Omega 3
Study: NCT02468037

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Phlebotomy
Description: Patients donate blood until tissue iron levels are in the lowest quartile of normal.
Study: NCT01557075

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pravastatin (High dose statin treatment)
Description: Patients will be randomly assigned to the type of statins. Randomization of statin therapy will be done 1:1 to one of two different statins on the web-based program~Pravastatin 20mg daily for 12 months after randomization
Study: NCT00572507

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MonoMax®
Description: Abdominal wall closure with ultra-longterm absorbable monofilament suture after primary median laparotomy
Study: NCT04002856

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Profhilo®
Description: Profhilo® (IBSA Farmaceutici Italia S.r.l.) is a resorbable medical device 2.25 ml non-pyrogenic pre-filled syringe, containing 2 ml of 3.2% hyaluronic acid for intradermal use (32 mg H-HA + 32 mg L-HA dissolved in 2 ml of saline buffered sodium chloride
Study: NCT04933188

Intervention type: DIAGNOSTIC_TEST
Intervention: Myocardial work was estimated from left ventricular pressure-strain loop derived from speckle tracking echocardiography and non-invasive brachial artery cuff pressure
Description: Baseline and follow-up examination of echocardiography is to be performed on study subjects.

Intervention type: DIAGNOSTIC_TEST
Intervention: Myocardial work was estimated from left ventricular pressure-strain loop derived from speckle tracking echocardiography and non-invasive brachial artery cuff pressure
Description: Baseline and follow-up examination of echocardiography is to be performed on study subjects.

Intervention type: DIAGNOSTIC_TEST
Intervention: Myocardial work was estimated from left ventricular pressure-strain loop derived from speckle tracking echocardiography and non-invasive brachial artery cuff pressure
Description: Baseline and follow-up examination of echocardiography is to be performed on study subjects.
Study: NCT04303598

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FNC
Description: 3mg, 1 tablet，QD

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3TC
Description: 300mg, 1 tablet，QD
Study: NCT02800148

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azelaic acid foam
Study: NCT02454413

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: denture brushing with water and soap
Description: denture brushing with water and soap

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: denture brushing with water and soap
Description: denture brushing with water and soap

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ultrasonic denture cleaning
Description: ultrasonic denture cleaning

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: ultrasonic denture cleaning
Description: ultrasonic denture cleaning

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cleansing tablet
Description: addition of a cleansing tablet to the water in which the dentures are stored overnight

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cleansing tablet
Description: addition of a cleansing tablet to the water in which the dentures are stored overnight
Study: NCT04622540

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: External biliary drainage
Description: Application of external biliary drainage through duct-to-duct anastomosis
Study: NCT02991651

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IRX4204
Description: RXR agonist

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IRX4204
Description: RXR agonist

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IRX4204
Description: RXR agonist

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib
Description: inhibitor of phosphorylation of the tyrosine kinase associated with the epidermal growth factor receptor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib
Description: inhibitor of phosphorylation of the tyrosine kinase associated with the epidermal growth factor receptor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: erlotinib
Description: inhibitor of phosphorylation of the tyrosine kinase associated with the epidermal growth factor receptor
Study: NCT03352804

Intervention type: OTHER
Intervention: Screening of MDR Bacteriae
Description: questionnaire will be filled by every patient
Study: NCT02800148

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azelaic acid foam

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Azelaic acid foam - Placebo
Study: NCT02052479

Intervention type: OTHER
Group type: OTHER
Intervention: Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT)

Intervention type: OTHER
Group type: OTHER
Intervention: Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT)
Study: NCT03970473

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary recruitment maneuver (PRM)- 30 cm H2O
Description: Pulmonary recruitment maneuver (PRM) consists of five manual pulmonary inflations where each positive pressure inflation will be performed for 5 s at a maximum pressure of 30 cm H2O in the semi-fowler position (30° head-of-bed elevation ). PRM is performed after LS when the main umbilical port is remaining and aims to remove the remaining gas following LS.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary recruitment maneuver (PRM)- 15 cm H2O
Description: Pulmonary recruitment maneuver (PRM) consists of five manual pulmonary inflations where each positive pressure inflation will be performed for 5 s at a maximum pressure of 15 cm H2O in the semi-fowler position (30° head-of-bed elevation ). PRM is performed after LS when the main umbilical port is remaining and aims to remove the remaining gas following LS.
Study: NCT01833403

Intervention type: OTHER
Group type: OTHER
Intervention: Hyperinsulinemic-euglycemic clamp
Description: Subject will received 6,6 2H2 Glucose prior and during a 4 hr hyperinsulinemic-euglycemic clamp to characterize hepatic insulin resistance prior to bariatric surgery~--------------------------------------------------------------------------------
Study: NCT03275558

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Axitinib 1 MG
Description: Pharmaceutical composition of Axitinib 5MG +Sunitinib 5MG + Pazopanib 5MG in the liquid form of a nasal spray NST-4-G.~Subjects take a nasal spray BID at a single dose in each nostril (approximately at the same time of day) for 7 weeks or unacceptable toxicity or other adverse events.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sunitinib 5 MG
Description: Pharmaceutical composition of Axitinib 5MG +Sunitinib 5MG + Pazopanib 5MG in the liquid form of a nasal spray NST-4-G.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pazopanib 5 MG
Description: Pharmaceutical composition of Axitinib 5MG +Sunitinib 5MG + Pazopanib 5MG in the liquid form of a nasal spray NST-4-G.
Study: NCT03430752

Intervention type: OTHER
Intervention: questionnaires
Description: Participants were asked to respond to the questionnaires including the Chinese version of the Paediatric Quality of Life Inventory 4.0 Generic Core Scale (PedsQL 4.0), the Chinese version of the Center for Epidemiological Studies Depression Scale for Children (CES-DC), the Chinese version of Rosenberg self-esteem scale, the Chinese version of the Herth Hope Index (HHI) and the Chinese version of Resilience Scale for Children (RS10).

Intervention type: OTHER
Intervention: questionnaires
Description: Participants were asked to respond to the questionnaires including the Chinese version of the Paediatric Quality of Life Inventory 4.0 Generic Core Scale (PedsQL 4.0), the Chinese version of the Center for Epidemiological Studies Depression Scale for Children (CES-DC), the Chinese version of Rosenberg self-esteem scale, the Chinese version of the Herth Hope Index (HHI) and the Chinese version of Resilience Scale for Children (RS10).
Study: NCT03359733

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-659
Description: TAK-659 tablet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-659
Description: TAK-659 tablet.
Study: NCT01482780

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PICSO
Description: PICSO (pressure controlled intermittent coronary sinus occlusion) will be used in the pre ECC period. The procedure of PICSO will be performed in analogy to retrograde cardioplegia.
Study: NCT04454450

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/MRI
Description: Imaging will include research PET/MRI of pelvis within 30 days of multiregion tissue collection.For research PET/MRI - standard volumes of gadolinium contrast and fluorodeoxyglucose (FDG) will be administered.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/MRI
Description: Imaging will include research PET/MRI of pelvis within 30 days of multiregion tissue collection.For research PET/MRI - standard volumes of gadolinium contrast and fluorodeoxyglucose (FDG) will be administered.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Contrast enhanced CT
Description: Standard of care contrast enhanced CT

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Contrast enhanced CT
Description: Standard of care contrast enhanced CT
Study: NCT01514318

Intervention type: DEVICE
Intervention: Revelation Hip Stem (Revelation)
Description: Subjects who received the Revelation Hip Stem prior to 2002 and still maintain the original device.
Study: NCT02751983

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT for Life
Description: A novel protocol detailing the application of Acceptance and Commitment Therapy (ACT) to recovery from suicidal crises. Consists of three modules designed to be delivered in three to four 60-minute individual talk therapy sessions. Nearly all of the metaphors and experiential exercises are adaptations of core ACT techniques included in various empirically-supported applications of ACT to other health conditions. Additionally, the adjunctive intervention is designed to augment safety planning (a hierarchical list of strategies to recognize and cope with a suicidal crisis).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: All participants will be able to engage in treatment as usual. Psychiatric inpatient care typically consists of behavioral mental health group and/or individual therapy and pharmacological treatment. Outpatient care is offered upon discharge. This typically consists of both group and individual therapy and medication management.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual
Description: All participants will be able to engage in treatment as usual. Psychiatric inpatient care typically consists of behavioral mental health group and/or individual therapy and pharmacological treatment. Outpatient care is offered upon discharge. This typically consists of both group and individual therapy and medication management.
Study: NCT00685932

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobius Retractor
Description: The Mobius retractor is a dual ring elastic self retaining retractor that is inserted into the abdominal cavity after the peritoneal incision has been established. It is then left in place during the hysterotomy incision, delivery of the fetus, hysterotomy repair, inspection and irrigation.
Study: NCT00381420

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: drug-eluting stent
Description: sirolimus-coated Bx VELOCITY Balloon-Expandable Stent

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: bare-metal stent
Description: un-coated Bx VELOCITY Stent
Study: NCT01800903

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ZN-D catheter
Description: ZN-D catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-D catheter
Description: ZN-D catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-D catheter
Description: ZN-D catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-D catheter
Description: ZN-D catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-D catheter
Description: ZN-D catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-D catheter
Description: ZN-D catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ZN-C catheter
Description: ZN-C catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-C catheter
Description: ZN-C catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-C catheter
Description: ZN-C catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-C catheter
Description: ZN-C catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-C catheter
Description: ZN-C catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZN-C catheter
Description: ZN-C catheter is a catheter, similar to the CE-marked SpeediCath, but with a newly developed coating.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SpeediCath catheter
Description: The Speedicath cathere is CE-marked and commercially available.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SpeediCath catheter
Description: The Speedicath cathere is CE-marked and commercially available.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SpeediCath catheter
Description: The Speedicath cathere is CE-marked and commercially available.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SpeediCath catheter
Description: The Speedicath cathere is CE-marked and commercially available.
Study: NCT04303598

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TDF
Description: 300mg, 1 tablet，QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TDF
Description: 300mg, 1 tablet，QD

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: EFV
Description: 200mg, 1 tablet，QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EFV
Description: 200mg, 1 tablet，QD

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FNC placebo
Description: 1 tablet，QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3TC placebo
Description: 1 tablet，QD
Study: NCT01078571

Intervention type: BIOLOGICAL
Intervention: adalimumab (HUMIRA®)
Description: The primary objective of the study is to evaluate the safety and tolerability of adalimumab (HUMIRA®) treatment, administered both in monotherapy and combined therapy, in rheumatoid arthritis (RA) patients under usual practice conditions.
Study: NCT02213458

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Navigated Care
Description: Navigated Care emphasizes continuous and personalized care and is based on 3 modules: the Caregiver Module that includes educational interventions and connects families with community resources, the Decision-Making Module that facilitates proactive medical, financial, and safety decisions, and the Medication Module that identifies inappropriate medication usage via pharmacist review. Innovative technology in the form of a dashboard functions as a patient care management system used by Care Team Navigators (CTNs).
Study: NCT04847908

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single high-intensity interval exercise intervention
Description: Study participants perform a single bout of exercise on a cycle ergometer (high-intensity interval exercise intervention) within the first and third cycle of chemotherapy. Following a 2 minute warm-up, the interval protocol comprises 10 intervals à 15 seconds with high intensity and 60 seconds low intensity in-between. Blood samples are taken at t0 pre-exercise (after a 10 minute rest) and at t1 immediately post-exercise via central catheter (Hickman/port).
Study: NCT04301102

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hemosphere platform® together with the FloTrac Acumen IQ® sensor
Description: Clinical platform that, analyzing the pulse wave contour, obtained from the previously catheterized radial artery, is able to make available to the clinician both a continuous monitoring of blood pressure and advanced hemodynamic parameters that help patient management. It incorporates predictive parameters such as the hypotension prediction index and decision support parameters such as dynamic arterial elastance and maximum dP / dT.~It also has the possibility of assessing regional oxygen saturation, measured by near-infrared light photoplethysmography, and the sensor can be applied in different locations (cerebral, muscular ...).

Intervention type: DEVICE
Group type: OTHER
Intervention: Hemosphere platform® together with the FloTrac® sensor
Description: Clinical platform that, analyzing the pulse wave contour, obtained from the previously catheterized radial artery, is able to make available to the clinician both a continuous monitoring of blood pressure and advanced hemodynamic parameters that help patient management.~It also has the possibility of assessing regional oxygen saturation, measured by near-infrared light photoplethysmography, and the sensor can be applied in different locations (cerebral, muscular ...).
Study: NCT00635323

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan plus capecitabine
Description: Irinotecan 200-250 mg/m2 intravenous infusion over 30 to 90 minutes on day 1 of a 3-week cycle. Capecitabine 1000 mg/m2 oral tablet twice daily for 14 days followed by a 7 day rest throughout the treatment period for
Study: NCT01721109

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EVG/COBI/FTC/TDF
Description: 150/150/200/300 mg STR administered orally once daily with food
Study: NCT01176409

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Description: Valacyclovir will be used at two different dosages (1g po BID and 500mg po BID) to be used for 12 weeks. Supplied as 500mg caplets.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Valacyclovir
Description: Valacyclovir will be used at two different dosages (1g po BID and 500mg po BID) to be used for 12 weeks. Supplied as 500mg caplets.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, supplied as caplets identical in appearance, odour and taste to valacyclovir 500mg caplets.
Study: NCT00006092

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arsenic Trioxide